RxDoctor Payments Data

Kyle Adams, MD

Family Medicine · Colorado Springs, CONPI 1508284431

Payments from drug & device makers

$3,730in general payments, 2019–2025

Across 241 payments — averaging $15.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$839
  • Novo Nordisk$442
  • Amgen$292
  • Boehringer Ingelheim$205
  • AstraZeneca$199
  • Novartis$169
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$3,730100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,730 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$109,890
Medicare patients
327
Services billed
1,098

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide42$65,493
TrulicityDulaglutide28$54,452
MounjaroTirzepatide48$53,838
EliquisApixaban18$30,979
XareltoRivaroxaban16$23,779
Tresiba Flextouch U-100Insulin Degludec12$6,807
Breo ElliptaFluticasone/Vilanterol15$6,656
SymbicortBudesonide/Formoterol Fumarate12$5,839
Fiasp FlextouchInsulin Aspart (Niacinamide)11$5,770
Dabigatran EtexilateDabigatran Etexilate Mesylate15$5,562
Estradiol27$3,053
Atorvastatin Calcium272$2,894
SynthroidLevothyroxine Sodium44$2,322
Lidocaine12$2,215
Gabapentin66$2,122

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$155$108,29176 claims
Novo NordiskOzempic$442$65,49342 claims
PfizerEliquis$156$30,97918 claims
Johnson & JohnsonXarelto$35$23,77916 claims
GSKBreo Ellipta$87$6,65615 claims
AstraZenecaSymbicort$199$5,83912 claims
AbbVieSynthroid$839$2,32244 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →